Background: Aim of the Cologne Infarction Model (KIM) is to examine the feasibility
Introduction
Primary percutaneous intervention (PCI) has been shown to be superior to fibrinolytic therapy in patients with ST-segment-elevation myocardial infarction (STEMI). The benefit of PCI is most pronounced when it is performed early after the onset of symptoms and close to the patient's first contact with medical professionals. 1, 2 This evidence has been reflected in recent guidelines for the treatment of acute myocardial infarction, 3, 4 recommending PCI as first line therapy provided that the time between first medical contact and first balloon inflation or the time between entering the hospital and the first balloon inflation is less than 90 minutes and the delay between the potential start of fibrinolytic therapy and the percutaneous coronary intervention is not more than 60 minutes.
In Germany, a number of hospitals provide a 24 hour coronary catheterization laboratory and organized networks exist to guide the patient with an acute STEMI into the catheterization laboratory without any delay. 5 However, precise data concerning the clinical results of these efforts remain sparse. For the US, it has been reported that less than one third of patients with STEMI receive primary PCI and that fewer than 40% are treated within 1.5 hours. 2, [6] [7] [8] This holds true despite the fact that in several regions both triage and transfer protocols for PCI in patients with STEMI have been developed. 2 Thus, there is no broad evidence in the literature proving the feasibility of PCI as first line therapy in patients with STEMI.
Cologne is a German city with >1 million citizens. Within the city, there are five cardiology departments with a cardiac catheterization facility equally distributed throughout the city and 11 primary care hospitals without catheterization facility. 
Methods

Patient Population
The data reflect 519 patients treated within KIM between January and December 2006. The aim of KIM was to collect data of patients with a STEMI treated within the medical system of Cologne regardless whether they were treated in a catheterization laboratory or otherwise. Inclusion of patients in the KIM registry occurred after initial diagnosis of STEMI regardless whether this was done by the emergency physician outside a hospital, by a physician in a hospital without a catheterization laboratory or in a cardiology unit with a catheterization laboratory. Inclusion was based on the 12-lead ECG criteria: ST-segment elevation of > 0.1 mV in two or more depending extremity leads, ST-segment elevation of > 0.2 mV in at least two neighbouring chest leads or left bundle branch block in combination with typical symptoms.
Transfer triage and treatment protocol
Prior to the start of KIM, the metropolitan emergency medical service, all 11 hospitals without and all 5 centres with a catheterization unit agreed that patients diagnosed with STEMI should no longer be transferred to the responsible district hospital.
Instead, they should be transferred directly to a cardiology unit with catheterization facility. The cardiology units were obliged to provide a catheterization laboratory and an emergency care unit available seven days a week for 24 hours. Activation of the catheterization lab and its staff had to be started after the diagnosis of STEMI by first medical contact. Thus, the mobilization of catheterization laboratory staff occurred immediately after announcement of a patient's transfer to the catheterizing hospital or after patient's arrival at this site. EMS physicians diagnosing a STEMI were asked to inform the responsible catheterization laboratory by phone and to deliver the patient directly to this facility. Admitting physicians in non catheterizing hospitals diagnosing a STEMI were also asked to inform the cooperating cardiology unit and to transfer the patient to its catheterization laboratory without any delay. Patients presenting at the emergency department of a hospital with a catheterization laboratory had to be transferred directly for coronary angiography and interventional treatment. The proposed patient pathway is shown in figure 1 . 
Data collection and quality management
Each patient included into the KIM treatment regimen was accompanied by a file consisting of seven separate protocol forms for each potential treatment step: check list of first medical contact, EMS treatment, admitting hospital without catheterization laboratory, catheterization laboratory intervention centre, discharging hospital without catheterization laboratory and, in addition, follow up questionnaire for general practitioners being addressed 3 months and 12 months after hospital discharge.
These forms guaranteed collection of important patient information throughout the complex medical system. Doctors treating the patient at the individual steps were asked to complete the forms, the time necessary for this procedure being less than 2 minutes. Missing data were added by a secondary study of the patient's hospital files.
All data were transferred to an electronic data base blinded for patient's names and personal data.
Central parameters for the evaluation of KIM were:
-quality of data documentation -adherence to treatment pathways -correctness of primary diagnosis -reaction times:
-time between first symptoms and first medical contact 
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Results
Patient Characteristics
Between Jan 1, 2006 and Dec 31, 2006, 519 patients were included into KIM. The number of participating patients was equally distributed throughout the whole year.
The smallest number of individuals included into KIM was 36 in September, the maximum number was 51 in February.
356 patients were male, 163 were female. The mean age of the patients was 63.4 + 13.9 years. 37.6 % of the patients were between 65 and 79 years of age. 13.3 % of the patients were eighty years or older.
At primary contact with the medical system, 15.2 % of the patients presented with signs of cardiogenic shock, defined as either cardiac arrest (6.5%) or severe inotropic failure (8.7%). In all these patients, ECG diagnosis of STEMI was confirmed by a qualified cardiologist. In addition, 74 % of these patients revealed a significant increase in creatinine kinase. The remaining 22 patients died early in the catheterization lab and no blood samples had been taken at all prior to death. In 13.3 % of all patients, resuscitation was performed by the EMS team and in 14.7 % of all patients, intubation and ventilation was necessary prior to the transfer to the intervention centre. 8% of all patients revealed a positive shock index with systolic blood pressure < 100 mm Hg and pulse rate > 100 beats/minute. 16.6 % of the patients received catecholamines during the EMS transport to the intervention centre and 5.6 % of the patients had to be resuscitated during this transport. On admission at the intervention centre, 15.2 % of the patients depended on catecholamines, 13.0 % were ventilated and 6.9 % had to be resuscitated. Patient characteristics are summarized in table 1.
Patient pathways through the medical system
122 (24%) of all patients primarily presented at a hospital without a catheterization facility and secondarily were transferred to a coronary intervention centre. 
Correctness of diagnosis
False positive inclusions were defined as diagnosis of STEMI by EMS doctor or admitting physician at a non coronary intervention hospital and exclusion of STEMI by the specialist in the admitting coronary intervention centre. False positive ECGinterpretation and patients' inclusion into KIM by EMS doctors occurred in 6% and by admitting physicians in non coronary intervention hospitals in 5% of their patients, respectively.
Reaction times
Reaction times are given in table 2. The main time delay for most patients was the interval between onset of symptoms and first contact within the medical system with a median symptom to contact time of 120 minutes.
Once the patient had been seen by a medical professional, median treatment times were all within the time limits as recommended by international guidelines. 
Intervention Rate und Results
As intended, coronary angiography rate was high. 516 patients were admitted at a 76 % of the patients with coronary angiography required stent implantation. 10% underwent coronary angioplasty without stent implantation. 5% were transferred to CABG surgery, either directly or after coronary angioplasty. In those undergoing coronary angioplasty, the success rate -defined as achievement of TIMI III flow -was 89 %.
Death and Re-Myocardial Infarction
Mortality was 12.1 % with two patients dying in their district hospital without transfer to an intervention centre and 61 patients dying after admission to a coronary intervention centre. 10 (1.9 %) patients experienced a re-infarction. For the 479 patients undergoing coronary angiography, mortality was 11.9 %. For comparison, mortality rate was analyzed for patients treated at the two biggest intervention centres of Cologne between January and June 2005, prior to the start of KIM.
Mortality rate among 308 patients treated at the two major coronary intervention centres in Cologne was 10.4%. One year later, between January and June 2006, after the start of KIM, mortality rate was 7.6% in these two centres.
Major determinants of mortality were old age and circulatory stage at primary contact or admission to the intervention centre. There was a significant trend of mortality increasing with age (p<0.001), with the mortality for patients at age 80 years and older being six times higher than for patients below 50 years of age (figure 3). Also, mortality was significantly increased in patients with cardiogenic shock. Patients being in shock (defined as either inotropic failure or cardiac arrest) at first medical contact had a mortality of 50%, whereas patients not being in shock had a mortality of 4.72%. Patients with inotropic failure (systolic blood pressure < 100 mm Hg) had a mortality of 36.1%. Within this group, those without need for resuscitation had a mortality of 16.9%, those with need for resuscitation had a mortality of 59.2%.
Patients with cardiac arrest (documented ventricular fibrillation) had a mortality of 55.9%. Risk factors for increased mortality are given in table 3.
Secondary preventive medication at discharge and follow up
Secondary preventive medication was defined as prescription of beta-blocker, ACEinhibitor, aspirin and statins at the time of hospital discharge. The criterion was met by 82.4% of patients being directly discharged from a hospital with coronary intervention unit and was met by 79.2% of patients being discharged from a hospital without coronary intervention unit. -ECG training and use of 12-lead ECG by the EMS provide sufficient competence for diagnosis of STEMI and initiation of treatment pathways.
-Despite all efforts, overall mortality remains high but is due to a high number of patients being treated by PCI despite very old age and unstable circulatory state.
The present data go beyond a recent report presenting results of the Viennese STEMI Registry. In Vienna, the metropolitan ambulance system cooperated with five interventional cardiology departments guaranteeing that a catheterization laboratory was available 24 hours a day in at least two alternating places. The primary triage of patients to either thrombolysis or PCI was performed by the EMS physicians.
Guideline implementation led to a marked increase in the percentage of patients receiving PCI as first line therapy, finally leading to a drop in in-hospital mortality from 16% to 9.5%. 9 The aim of KIM was to guarantee PCI in time as primary therapy for all STEMI patients within a city of 1 million citizens. As consequence, the Cologne EMS, all coronary intervention centres and all regular hospitals within Cologne agreed to provide an infrastructure guaranteeing a contact-to-balloon and phone-toballoontime of less than 90 minutes during 24 hours to every patient presenting with STEMI. Only 2 out of 591 patients with a STEMI were not transferred into a coronary intervention centre; the majority of patients underwent coronary angiography and angioplasty. This supports the finding that the prevalence of normal coronary angiography in acute STEMI is below 3%. 10 As in Vienna, also in KIM delay times were within the time limits requested by AHA, ESC and national guidelines. 11 12 Thus, the consequent guideline implementation in a metropolitan area enables PCI as obligatory first line therapy for STEMI. 13 14 Only recently, activation of the catheterization laboratory by EMS while the patient is on its way and staff arriving at the catheterization facility within 20 minutes after being paged, have been named as major strategies leading to a decrease in treatment delay. 15 Data of the KIM registry confirm that this approach leads to short delay times and prompt coronary interventions. One of the most important innovations was triage responsibility of the EMS physician. KIM proves that activation of the catheterization team by EMS staff does only rarely lead to "false alarm". Nearly all patients (93 %) who were transferred into a coronary intervention centre had an indication for emergency coronary angiography and intervention. Thus, EMS doctors equipped with a 12-lead ECG develop sufficient diagnostic competence for handling the therapeutic triage in STEMI patients. The specificity of diagnosis based on prehospital 12-lead ECG as observed in this study is similar to that in an assessment of the US American Agency for Healthcare Research and Quality, which calculated the specificity of pre-hospital 12-lead ECG based diagnosis being 97%. 16 It was even higher than in a recent report from San Diego in which specificity of ECG based diagnosis was 78% in the hands of paramedics and 96%, if ECG was interpreted by physicians after electronic transfer 17 The number of patients included into KIM within 12 months was lower than expected.
Based on data of the MONICA trial obtained in the region around Augsburg, a city in southern Germany, it can be expected that there are 1800 patients with a STEMI per 1 million citizens per year. 18 Since the intention of the KIM organizers was to include The hypothesis that patients might not reach a hospital or might not even get in touch with a medical professional is reflected by the threatening observation that the median time between onset of symptoms and first medical contact is 120 minutes.
The impact of time delay until first medical contact on the increase in mortality has been characterized very well. 19 The long symptom-to-contact-time is another argument in favour of PCI because thrombolysis is mainly efficient within the first two hours after the onset of symptoms.
6, 20, 21 22 KIM did not lead to a major reduction in mortality. As a matter of fact, a mortality of 12.1% is higher than in many other trials comparing thrombolysis and PCI for the STEMI therapy. 20, 23 10 One explanation is that a high number of patients presented with cardiogenic shock, defined as either patients who primarily survived cardiac arrest or with inotropic failure. These patients had a tenfold increased risk of death compared to patients without shock, which was similar to a 25 fold increase in the risk of death for patients with cardiogenic shock in the Vienna STEMI registry. 9 More precisely, mortality rate in patients with cardiac arrest was 56%. In patients with inotropic failure mortality was 39%. In contrast, in patients without cardiac arrest or inotropic failure mortality was 5%. This confirms earlier data collected by a group of German hospital cardiologist in 4815 STEMI patients who demonstrated that cardiogenic shock led to an increase in in-hospital mortality from 4% to 40% and was a more important determinant of mortality than in-hospital treatment time. 24 Another reason might be the high percentage of patients of high age in the KIM registry. In the MITRA PLUS registry comparing the effects of thrombolysis and PCI in STEMI patients being older than 70 years, mortalities were 17.8% and 12.5%, respectively.
In KIM, mortality for patients being 80 years and older was 24.6% in contrast to a mortality of 10.2% for patients younger than 80. 25 The number of patients presenting with cardiogenic shock or at very old age increased between the period before KIM and after initiation of KIM. E.g., in the two major coronary intervention centres, 8% of the patients were 80 years and older and 9. There are a number of limitations of this study. Some concerns have been mentioned already: There is no control for false negative diagnoses leading to an exclusion of patients because of ECG misdiagnosis. Thus, there is no evaluation how many patients with STEMI were missed despite getting in touch with the medical system.
Also, so far, there have been no regular audits of the participating hospitals controlling for patients diagnosed as suffering from STEMI but not included into KIM.
However, comparing the KIM data of two randomly chosen KIM hospitals with their own ICD statistics makes us believe that the presented data do reflect the reality in Triage for patients with a STEMI in KIM. 
